Lang Ninian N, Badar Athar A, Pettit Stephen J, Templeton Sheena, Connelly Derek T, Gardner Roy S
Scottish Advanced Heart Failure Service, Golden Jubilee National Hospital, Agamemnon Street, Clydebank, Glasgow, G81 4DY, UK.
Biomark Med. 2014;8(6):797-806. doi: 10.2217/bmm.13.159.
Effective cardiac resynchronization therapy may depend upon the distance between left ventricular (LV) and right ventricular (RV) pacing leads. We assessed the influence of lead separation upon circulating NT-proBNP.
MATERIALS & METHODS: In total, 132 patients underwent assessment, including NT-proBNP assay, before and after cardiac resynchronization therapy. 3D lead separation was calculated from postero-anterior and lateral chest radiography.
Lead separation correlated with NT-proBNP reduction (r = 0.25; p = 0.004). Circulating NT-proBNP only fell in those with lead separation in the upper two quartiles. Deteriorating NT-proBNP occurred in 44 patients. Lead separation was less in these patients compared with those with an improvement (corrected 3D lead separation: 148.0 ± 5.38 and 170.5 ± 4.21 mm, respectively; p = 0.0018).
Left ventricular-right ventricular lead separation correlates with postcardiac resynchronization therapy improvements in circulating NT-proBNP, a powerful marker of heart failure status and prognosis. Attention should be paid to achieving maximal lead separation at implantation.
有效的心脏再同步治疗可能取决于左心室(LV)和右心室(RV)起搏导线之间的距离。我们评估了导线间距对循环中N末端脑钠肽前体(NT-proBNP)的影响。
共有132例患者在心脏再同步治疗前后接受了评估,包括NT-proBNP检测。通过后前位和侧位胸部X线片计算三维导线间距。
导线间距与NT-proBNP降低相关(r = 0.25;p = 0.004)。仅在导线间距处于上两个四分位数的患者中,循环NT-proBNP下降。44例患者的NT-proBNP恶化。与病情改善的患者相比,这些患者的导线间距更小(校正后的三维导线间距分别为:148.0±5.38和170.5±4.21mm;p = 0.0018)。
左心室-右心室导线间距与心脏再同步治疗后循环NT-proBNP的改善相关,NT-proBNP是心力衰竭状态和预后的有力标志物。植入时应注意实现最大导线间距。